Skip to main content
Pharos iBio Co., Ltd. logo

Pharos iBio Co., Ltd. — Investor Relations & Filings

Ticker · 388870 ISIN · KR7388870008 KO Professional, scientific and technical activities
Open in API
Filings indexed 83 across all filing types
Latest filing 2026-04-13 Investor Presentation
Country KR South Korea
Listing KO 388870

About Pharos iBio Co., Ltd.

https://www.pharosibio.com/en/

Pharos iBio is a clinical-stage biotechnology company that specializes in drug discovery and development. The company leverages a proprietary platform based on artificial intelligence (AI) and big data to identify and create novel therapeutic candidates. Its primary focus is on developing treatments for rare and refractory diseases, with a significant emphasis on oncology. The development pipeline includes assets that are progressing through clinical trials, such as a therapy for acute myeloid leukemia.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Investor Presentation Classification · 1% confidence The document is an announcement of an upcoming corporate Investor Relations briefing (기업설명회 IR) including date, time, venue, participants, agenda, sponsor, contact details, and IR material posting information. This is a notice of an investor presentation event, matching the definition of an Investor Presentation (IP).
2026-04-13 Korean
본점소재지변경
Regulatory Filings Classification · 1% confidence The document is a regulatory announcement of the company’s change of its head office location (address update), not a financial report or management change notice. It does not fit any specific category like share issues, dividends, or director dealings. Therefore it falls under the fallback category “Regulatory Filings.”
2026-03-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a post-meeting disclosure of the results from the company’s Annual General Meeting (“정기주주총회결과”). It lists the results of each agenda item, voting percentages, and related details such as approval of financial statements, dividend resolutions, director elections, and other shareholder votes. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-03-27 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a formal notification filed with the Financial Services Commission/Korea Exchange regarding the appointment/reappointment of an outside (independent) director at Pharos I Bio Co., Ltd. It details the director’s name, appointment date, term, and related corporate governance information. This matches the definition for Board/Management Information (MANG) which covers announcements of changes in the company’s board of directors or senior management.
2026-03-27 Korean
사업보고서 (2025.12)
Annual Report Classification · 1% confidence The document is a 'Business Report' (사업보고서) for Pharos iBio Co., Ltd. for the 10th fiscal year (2025). It contains comprehensive information including company overview, history, capital structure, and detailed business descriptions (R&D pipelines, clinical trial status, and financial data). In the South Korean regulatory context (DART system), the '사업보고서' is the equivalent of the US 10-K annual report, providing full-year financial and operational disclosures. FY 2025
2026-03-19 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) titled '감사보고서 제출' (Submission of Audit Report). It provides a summary of financial data, audit opinions, and key financial metrics (assets, liabilities, profit/loss) for the fiscal year. According to the 'Menu vs Meal' rule, this is a standard regulatory announcement (RPA) informing the public that the audit report has been submitted and providing the key highlights, rather than the full, multi-page audit report document itself. FY 2025
2026-03-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.